Sofosbuvir approved for chronic hepatitis C infection

Am J Health Syst Pharm. 2014 Jan 15;71(2):90. doi: 10.2146/news140006.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval
  • Drug Therapy, Combination
  • Genotype
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / genetics
  • Humans
  • Interferons / adverse effects
  • Interferons / therapeutic use
  • Ribavirin / therapeutic use
  • Sofosbuvir
  • United States
  • United States Food and Drug Administration
  • Uridine Monophosphate / administration & dosage
  • Uridine Monophosphate / analogs & derivatives*
  • Uridine Monophosphate / therapeutic use

Substances

  • Ribavirin
  • Interferons
  • Uridine Monophosphate
  • Sofosbuvir